Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
Raman Sankar, MD, PhD
Scott Aaronson, MD
Optimizing VNS Parameters: Keys to Therapeutic Success
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
VNS: Beyond Seizure Control
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
Cynthia J. Bither, ACNP-BC, MSN
Andrea Wallace, MSN, FNP-C, HF-Cert
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Precision Medicine in IgAN: A Deep Dive Into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
September 19, 2025
Prague
Impact of Barostim on Heart Failure Hospitalization
Jacob Abraham, MD
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Managing Patients With AAV in the Rheumatology Clinic
Andreas Kronbichler, MD
Bernhard Hellmich, MD
Optimizing AAV Outcomes: Maintenance Therapies
Silke R. Brix, MD, MRCP, SCPR
Don't Miss It! Rapid & Accurate AAV Diagnosis
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD